Sleep Experts

Walker’s clearest commercial thesis is to protect against the consequences of insufficient sleep rather than merely sell more sleep. He says his team has raised a funding round and is preparing a clinical trial for a pharmacological suite aimed at sleep-loss consequences: “I don’t care how much you sleep. I truly don’t.”

The episode treats “tired but wired” insomnia as a stress-system problem before it is a supplement problem. Walker cites limited, non-sleep-specific evidence for phosphatidylserine and ashwagandha, describes trying something in the roughly 300–400 mg range with 2–3 g of glycine, and keeps behavioral interventions central.

Geopolitical stress makes attention management part of sleep hygiene. Huffington recommends entering “the eye of the hurricane”: stop nighttime doomscrolling and set a news cutoff. She recommends turning off notifications that do not come from people you know; after Diamandis narrows that to people you love, she agrees, adding that 99.9% of “breaking news” is not breaking news.

Melatonin combines a narrow use case with conspicuous dosing and quality-control risk. Walker calls 1–3 mg physiological, versus common 5–20 mg doses, while one 20-vendor study found contents ranging from 83% below to 464% above the label—a “Wild West” market. His core distinction: melatonin generally changes sleep timing, not sleep generation.

Jet-lag adaptation requires synchronizing several biological signals, not finding one magic pill. Walker recommends switching clocks immediately, matching destination wakefulness, avoiding in-flight alcohol and caffeine, creating 10–12 hours of wakefulness before bedtime, then aligning daylight, exercise, meals, a hot bath or shower and 3 mg of melatonin.

Wearable scores cannot establish biological resilience to chronic short sleep. Walker recommends comparing blood panels after a stable two-week period and during intense travel because consumer stress metrics do not reach cells or organs; his population estimate for people sleeping under seven hours without measurable impairment on his measures, rounded to a whole percentage, is “zero.”

Sleep pharmacology repeatedly carries a no-free-lunch warning. Restless legs treatment can escalate from gabapentin or pregabalin to dopamine-modulating pramipexole and eventually opioid-like drugs, while long-term weekly modafinil evidence remains sparse; Walker says people he knows reserve it for “break glass” situations because “when you fight biology you normally lose.”

Sex and sleep appear mutually reinforcing in the figures Walker cites. Walker says orgasm results in about a 70–73% improvement in subjective sleep quality, self-stimulation can get “about 50% of the way there,” and each extra hour of sleep above a woman’s norm increased interest in intimacy by 14%, versus roughly 24% for libido drugs.

🔗 Original source & video: Sleep Experts: Melatonin, Sex, and their impact on Sleep w/ Arianna Huffington & Matt Walker | #168